PUBLISHER: The Business Research Company | PRODUCT CODE: 1929926
PUBLISHER: The Business Research Company | PRODUCT CODE: 1929926
Citrus bioflavonoids are natural compounds found in citrus fruits such as oranges and lemons, recognized for their antioxidant, anti-inflammatory, and immune-boosting effects. They are commonly included in supplements to promote heart health, enhance immunity, and aid in the absorption of vitamin C.
The main types of citrus bioflavonoids include diosmin, eriocitrin, hesperidin, naringenin, nobiletin, quercitrin, rutin, and tangeritin. Diosmin, in particular, is a natural compound predominantly found in citrus peels and is often used to improve blood circulation and address venous diseases. Key sources of these compounds include grape peel, lemon and lime peel, and orange peel. They are available in various forms, such as gummies, powders, and tablets. These bioflavonoids are utilized by a diverse range of end-users, including those in animal feed, cosmetics and personal care, dietary supplements and nutraceuticals, food and beverages, and pharmaceuticals.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
Tariffs are influencing the citrus bioflavonoids market by increasing costs of imported citrus peels, extraction equipment, processing chemicals, and purification technologies. Supplement and nutraceutical manufacturers in North America and Europe are most affected due to dependence on imported raw materials, while Asia-Pacific faces cost pressure on bioflavonoid exports. These tariffs are increasing ingredient prices and affecting formulation costs. At the same time, they are encouraging regional citrus sourcing, local extraction facilities, and investments in domestic bioactive ingredient production.
The citrus bioflavonoids market research report is one of a series of new reports from The Business Research Company that provides citrus bioflavonoids market statistics, including citrus bioflavonoids industry global market size, regional shares, competitors with a citrus bioflavonoids market share, detailed citrus bioflavonoids market segments, market trends and opportunities, and any further data you may need to thrive in the citrus bioflavonoids industry. This citrus bioflavonoids market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The citrus bioflavonoids market size has grown rapidly in recent years. It will grow from $1.32 billion in 2025 to $1.45 billion in 2026 at a compound annual growth rate (CAGR) of 10.3%. The growth in the historic period can be attributed to growing consumption of dietary supplements, increased awareness of antioxidant benefits, expansion of vitamin c fortification practices, availability of citrus processing byproducts, growth of preventive healthcare trends.
The citrus bioflavonoids market size is expected to see rapid growth in the next few years. It will grow to $2.15 billion in 2030 at a compound annual growth rate (CAGR) of 10.3%. The growth in the forecast period can be attributed to rising demand for immune health supplements, expansion of nutraceutical and functional food markets, increasing focus on natural ingredient sourcing, advancements in bioflavonoid extraction technologies, growing use of bioactives in pharmaceuticals. Major trends in the forecast period include increasing use of citrus-derived antioxidants in supplements, rising demand for plant-based nutraceutical ingredients, growing adoption of clean-label bioflavonoid products, expansion of bioflavonoid applications in functional foods, enhanced focus on high-purity extraction methods.
The increasing demand for natural and organic products is expected to drive the growth of the citrus bioflavonoids market in the coming years. Natural and organic products are produced using natural ingredients, without the inclusion of synthetic chemicals or artificial additives. The rising demand for these products is driven by growing health awareness, environmental concerns, and a strong preference for chemical-free alternatives. Citrus bioflavonoids are gaining considerable popularity within the natural and organic products market as consumers increasingly look for plant-based ingredients that promote overall health and wellness in a sustainable and chemical-free manner. For example, according to the Organic Trade Association, a US-based organization that supports the organic trade, U.S. organic sales reached $71.6 billion in 2024, reflecting a 5.2% increase from the previous year and double the growth rate of the overall food market. Therefore, the growing demand for natural and organic products is driving the expansion of the citrus bioflavonoids market.
Leading companies in the citrus bioflavonoids market are focused on creating innovative products that utilize Eriomin lemon fruit extract to assist with blood sugar regulation, improve metabolic health, and provide antioxidant benefits, addressing the rising consumer demand for natural, functional ingredients in health products and supplements. Eriomin is a standardized, high-potency lemon bioflavonoid blend that supports health by enhancing antioxidant activity and improving the body's insulin response. For example, in September 2024, Lemme, a U.S.-based dietary supplement manufacturer, introduced Lemme GLP-1 Daily, a new weight management supplement featuring three main ingredients, Eriomin lemon fruit extract, Supresa saffron extract, and Morosil red orange fruit extract. This product is positioned as a natural alternative to prescription GLP-1 medications such as Ozempic, aiming to stimulate the body's natural GLP-1 production, curb appetite, and promote healthy weight loss. It is being studied for its anti-inflammatory and antioxidant properties, which may support metabolic health and appetite regulation.
In November 2024, Miura Partners S.G.E.I.C. S.A., a Spain-based private equity firm focused on investing in sustainable natural-ingredient and specialty-chemicals companies, acquired HealthTech BioActives (HTBA) for an undisclosed amount. Through this acquisition, Miura Partners seeks to accelerate HTBA's international growth and scale its natural-ingredient production capabilities, strengthening its ability to serve pharmaceutical, nutraceutical, food, beverage, and animal-nutrition markets worldwide. HealthTech BioActives (HTBA) is a Spain-based manufacturer specializing in citrus flavonoids and active forms of vitamin B12, along with related natural ingredients, used across health, nutrition, food and beverage, and animal-nutrition applications.
Major companies operating in the citrus bioflavonoids market are Dohler Group, Kemin Industries Inc., Herbalife Nutrition Ltd., Natural Factors USA, Green Sky Biological, Life Extension Foundation Inc., Nans Products, Country Life LLC, NutraBlend Foods LLC, Cayman Chemical, Selleck Chemicals LLC, Solgar Inc., Aloha Medicinals Inc., Bordas S.A.S, Botanic Healthcare, BOC Sciences, Freeda Vitamins Inc., Sundown Naturals, NutraScience Labs, Paradise Herbs Inc
North America was the largest region in the citrus bioflavonoids market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the citrus bioflavonoids market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the citrus bioflavonoids market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The citrus bioflavonoids market consists of sales of functional foods, herbal extracts, and fortified beverages. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Citrus Bioflavonoids Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses citrus bioflavonoids market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for citrus bioflavonoids ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The citrus bioflavonoids market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.